We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Evolve Intellectual Property joins the ranking this year having continued to expand its client roster. Lead partner Stephen Gurney built up extensive in-house experience before forming the firm in 2022. He is a European, UK and Australian patent attorney, and he combines strong pharmaceutical and IP knowledge to assist with drug development and IP, portfolio management and prosecution, licensing, due diligence, and litigation. He recently assisted biopharmaceutical company Pharma Mar S.A. with the development of its UP strategy.
Legal 500 Editorial commentary
Key clients
- Pharma Mar S.A.
- DRI Healthcare
Abbreviated data is displayed for this firm.
Work highlights
Advised DRI Healthcare in relation to two Royalty Purchase Agreements for elacestrant worth $225 million.
- Advised OMERS Life Sciences in relation to the purchase of a Portion of Global Royalties for MAVYRET® worth $200 million.
Abbreviated data is displayed for this firm.